The market is witnessing robust growth due to the increasing complexity of clinical trials, rising patient-centric approaches ...

From 28 April, IVDs used clinical trials will be subject to an upfront assessment by the MHRA as part of a Clinical Trial of ...

DelveInsight's Oncolytic Virus Competitive Landscape 2026 report provides comprehensive global coverage of pipeline oncolytic ...

AstraZeneca's $15 billion pledge to its China operations highlights the country's advantages. But other regions are also hoping to host more clinical studies.

In a new draft guidance issued on January 14, 2026, the FDA discussed the use of a modern statistical methodology in clinical trials designed to ...

In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of ...

Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand enrolment.

When trial participants aren't representative, the evidence for universally adopted cancer treatment guidelines is incomplete ...

In a new publication, researchers from the German Center for Diabetes Research (DZD) and the University of Medicine ...

Many times, when people think about joining clinical trials, getting a doctor’s referral is the first thing that comes to ...

Slope is the only end-to-end, vendor-agnostic platform for managing biospecimens and clinical inventory across the entire clinical research ecosystem. Trusted by 2,200+ sites in 23+ countries, Slope ...

AI is rapidly entering clinical care, but malpractice law has not kept pace. As adoption accelerates, clinicians are being ...